-
1
-
-
2642651899
-
Differential expression of the Kell blood group and CD10 antigens: Two related membrane metallopeptidases duringdifferentiation of K562 cells by phorbol ester and hemin
-
Belhacene N, Maulon L, Guerin S, Ricci JE, Mari B, Colin Y et al. (1998). Differential expression of the Kell blood group and CD10 antigens: two related membrane metallopeptidases duringdifferentiation of K562 cells by phorbol ester and hemin. FASEB J 12: 531-539.
-
(1998)
FASEB J
, vol.12
, pp. 531-539
-
-
Belhacene, N.1
Maulon, L.2
Guerin, S.3
Ricci, J.E.4
Mari, B.5
Colin, Y.6
-
2
-
-
0033816156
-
Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors
-
Buchdunger E, Cioffi CL, Law N, Stover D, Ohno-Jones S, Druker BJ et al. (2000). Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J Pharmacol Exp Ther 295: 139-145.
-
(2000)
J Pharmacol Exp Ther
, vol.295
, pp. 139-145
-
-
Buchdunger, E.1
Cioffi, C.L.2
Law, N.3
Stover, D.4
Ohno-Jones, S.5
Druker, B.J.6
-
3
-
-
2542475112
-
Caspase-3 has a nonapoptotic function in erythroid maturation
-
Carlile GW, Smith DH, Wiedmann M. (2004). Caspase-3 has a nonapoptotic function in erythroid maturation. Blood 103: 4310-4316.
-
(2004)
Blood
, vol.103
, pp. 4310-4316
-
-
Carlile, G.W.1
Smith, D.H.2
Wiedmann, M.3
-
4
-
-
0034670036
-
The molecular biology of chronic myeloid leukemia
-
Deininger MW, Goldman JM, Melo JV. (2000). The molecular biology of chronic myeloid leukemia. Blood 96: 3343-3356.
-
(2000)
Blood
, vol.96
, pp. 3343-3356
-
-
Deininger, M.W.1
Goldman, J.M.2
Melo, J.V.3
-
5
-
-
0037082489
-
Regulation of the Erk2-Elk1 signaling pathway and megakaryocytic differentiation of Bcr-Abl(+) K562 leukemic cells by Gab2
-
Dorsey JF, Cunnick JM, Mane SM, Wu J. (2002). Regulation of the Erk2-Elk1 signaling pathway and megakaryocytic differentiation of Bcr-Abl(+) K562 leukemic cells by Gab2. Blood 99: 1388-1397.
-
(2002)
Blood
, vol.99
, pp. 1388-1397
-
-
Dorsey, J.F.1
Cunnick, J.M.2
Mane, S.M.3
Wu, J.4
-
6
-
-
0034254249
-
Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor
-
Heinrich MC, Griffith DJ, Druker BJ, Wait CL, Ott KA, Zigler AJ. (2000). Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor. Blood 96: 925-932.
-
(2000)
Blood
, vol.96
, pp. 925-932
-
-
Heinrich, M.C.1
Griffith, D.J.2
Druker, B.J.3
Wait, C.L.4
Ott, K.A.5
Zigler, A.J.6
-
7
-
-
7644231187
-
Cleavage of Mcl-1 by caspases impaired its ability to counteract Bim-induced apoptosis
-
Herrant M, Jacquel A, Marchetti S, Belhacene N, Colosetti P, Luciano F et al. (2004). Cleavage of Mcl-1 by caspases impaired its ability to counteract Bim-induced apoptosis. Oncogene 23: 7863-7873.
-
(2004)
Oncogene
, vol.23
, pp. 7863-7873
-
-
Herrant, M.1
Jacquel, A.2
Marchetti, S.3
Belhacene, N.4
Colosetti, P.5
Luciano, F.6
-
8
-
-
0012907461
-
A novel pyridopyrimidine inhibitor of abl kinase is a picomolar inhibitor of Bcr-abl-driven K562 cells and is effective against STI571-resistant Bcr-abl mutants
-
Huron DR, Gorre ME, Kraker AJ, Sawyers CL, Rosen N, Moasser MM. (2003). A novel pyridopyrimidine inhibitor of abl kinase is a picomolar inhibitor of Bcr-abl-driven K562 cells and is effective against STI571-resistant Bcr-abl mutants. Clin Cancer Res 9: 1267-1273.
-
(2003)
Clin Cancer Res
, vol.9
, pp. 1267-1273
-
-
Huron, D.R.1
Gorre, M.E.2
Kraker, A.J.3
Sawyers, C.L.4
Rosen, N.5
Moasser, M.M.6
-
9
-
-
32244434821
-
A survey of the signaling pathways involved in megakaryocytic differentiation of the human K562 leukemia cell line by molecular and c-DNA array analysis
-
Jacquel A, Herrant M, Defamie V, Belhacene N, Colosetti P, Marchetti S et al. (2006). A survey of the signaling pathways involved in megakaryocytic differentiation of the human K562 leukemia cell line by molecular and c-DNA array analysis. Oncogene 25: 781-794.
-
(2006)
Oncogene
, vol.25
, pp. 781-794
-
-
Jacquel, A.1
Herrant, M.2
Defamie, V.3
Belhacene, N.4
Colosetti, P.5
Marchetti, S.6
-
10
-
-
0642303647
-
Imatinib induces mitochondria-dependent apoptosis of the Bcr-Abl-positive K562 cell line and its differentiation toward the erythroid lineage
-
Jacquel A, Herrant M, Legros L, Belhacene N, Luciano F, Pages G et al. (2003). Imatinib induces mitochondria-dependent apoptosis of the Bcr-Abl-positive K562 cell line and its differentiation toward the erythroid lineage. FASEB J 17: 2160-2162.
-
(2003)
FASEB J
, vol.17
, pp. 2160-2162
-
-
Jacquel, A.1
Herrant, M.2
Legros, L.3
Belhacene, N.4
Luciano, F.5
Pages, G.6
-
11
-
-
1442355343
-
Inactivation of ERK accelerates erythroid differentiation of K562 cells induced by herbimycin A and STI571 while activation of MEK1 interferes with it
-
Kawano T, Horiguchi-Yamada J, Iwase S, Furukawa Y, Kano Y, Yamada H. (2004). Inactivation of ERK accelerates erythroid differentiation of K562 cells induced by herbimycin A and STI571 while activation of MEK1 interferes with it. Mol Cell Biochem 258: 25-33.
-
(2004)
Mol Cell Biochem
, vol.258
, pp. 25-33
-
-
Kawano, T.1
Horiguchi-Yamada, J.2
Iwase, S.3
Furukawa, Y.4
Kano, Y.5
Yamada, H.6
-
12
-
-
1242317094
-
Different roles of p38 MAPK and ERK in STI571-induced multi-lineage differentiation of K562 cells
-
Kohmura K, Miyakawa Y, Kawai Y, Ikeda Y, Kizaki M. (2004). Different roles of p38 MAPK and ERK in STI571-induced multi-lineage differentiation of K562 cells. J Cell Physiol 198: 370-376.
-
(2004)
J Cell Physiol
, vol.198
, pp. 370-376
-
-
Kohmura, K.1
Miyakawa, Y.2
Kawai, Y.3
Ikeda, Y.4
Kizaki, M.5
-
13
-
-
0037131970
-
Raf-1 antagonizes erythroid differentiation by restrainingcaspase activation
-
Kolbus A, Pilat S, Husak Z, Deiner EM, Stengl G, Beug H et al. (2002). Raf-1 antagonizes erythroid differentiation by restrainingcaspase activation. J Exp Med 196: 1347-1353.
-
(2002)
J Exp Med
, vol.196
, pp. 1347-1353
-
-
Kolbus, A.1
Pilat, S.2
Husak, Z.3
Deiner, E.M.4
Stengl, G.5
Beug, H.6
-
14
-
-
24744456935
-
Nuclear substructure reorganization duringlate-stag e erythropoiesis is selective and does not involve caspase cleavage of major nuclear substructural proteins
-
Krauss SW, Lo AJ, Short SA, Koury MJ, Mohandas N, Chasis JA. (2005). Nuclear substructure reorganization duringlate-stag e erythropoiesis is selective and does not involve caspase cleavage of major nuclear substructural proteins. Blood 106: 2200-2205.
-
(2005)
Blood
, vol.106
, pp. 2200-2205
-
-
Krauss, S.W.1
Lo, A.J.2
Short, S.A.3
Koury, M.J.4
Mohandas, N.5
Chasis, J.A.6
-
15
-
-
25144471855
-
Fast apoptosis and erythroid differentiation induced by imatinib mesylate in JURL-MK1 cells
-
Kuzelova K, Grebenova D, Marinov I, Hrkal Z. (2005). Fast apoptosis and erythroid differentiation induced by imatinib mesylate in JURL-MK1 cells. J Cell Biochem 95: 268-280.
-
(2005)
J Cell Biochem
, vol.95
, pp. 268-280
-
-
Kuzelova, K.1
Grebenova, D.2
Marinov, I.3
Hrkal, Z.4
-
16
-
-
23444443367
-
Vital functions for lethal caspases
-
Launay S, Hermine O, Fontenay M, Kroemer G, Solary E, Garrido C. (2005). Vital functions for lethal caspases. Oncogene 24: 5137-5148.
-
(2005)
Oncogene
, vol.24
, pp. 5137-5148
-
-
Launay, S.1
Hermine, O.2
Fontenay, M.3
Kroemer, G.4
Solary, E.5
Garrido, C.6
-
17
-
-
10744233716
-
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia
-
O'Brien SG, Guilhot F, Larson RA, Gathmann I, Baccarani M, Cervantes F et al. (2003). Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 348: 994-1004.
-
(2003)
N Engl J Med
, vol.348
, pp. 994-1004
-
-
O'Brien, S.G.1
Guilhot, F.2
Larson, R.A.3
Gathmann, I.4
Baccarani, M.5
Cervantes, F.6
-
18
-
-
1542283719
-
A novel mechanism for imatinib mesylate-induced cell death of BCR-ABL-positive human leukemic cells: Caspase-independent, necrosis-like programmed cell death mediated by serine protease activity
-
Okada M, Adachi S, Imai T, Watanabe K, Toyokuni SY, Ueno M et al. (2004). A novel mechanism for imatinib mesylate-induced cell death of BCR-ABL-positive human leukemic cells: caspase-independent, necrosis-like programmed cell death mediated by serine protease activity. Blood 103: 2299-2307.
-
(2004)
Blood
, vol.103
, pp. 2299-2307
-
-
Okada, M.1
Adachi, S.2
Imai, T.3
Watanabe, K.4
Toyokuni, S.Y.5
Ueno, M.6
-
19
-
-
2942558439
-
Role of the p38 mitogen-activated protein kinase pathway in the generation of the effects of imatinib mesylate (STI571) in BCR-ABL-expressing cells
-
Parmar S, Katsoulidis E, Verma A, Li Y, Sassano A, Lal L et al. (2004). Role of the p38 mitogen-activated protein kinase pathway in the generation of the effects of imatinib mesylate (STI571) in BCR-ABL-expressing cells. J Biol Chem 279: 25345-25352.
-
(2004)
J Biol Chem
, vol.279
, pp. 25345-25352
-
-
Parmar, S.1
Katsoulidis, E.2
Verma, A.3
Li, Y.4
Sassano, A.5
Lal, L.6
-
20
-
-
0037383849
-
Caspase activation is not death
-
Perfettini JL, Kroemer G. (2003). Caspase activation is not death. Nat Immunol 4: 308-310.
-
(2003)
Nat Immunol
, vol.4
, pp. 308-310
-
-
Perfettini, J.L.1
Kroemer, G.2
-
21
-
-
0037330623
-
The protein tyrosine phosphatase HePTP regulates nuclear translocation of ERK2 and can modulate megakaryocytic differentiation of K562 cells
-
Pettiford SM, Herbst R. (2003). The protein tyrosine phosphatase HePTP regulates nuclear translocation of ERK2 and can modulate megakaryocytic differentiation of K562 cells. Leukemia 17: 366-378.
-
(2003)
Leukemia
, vol.17
, pp. 366-378
-
-
Pettiford, S.M.1
Herbst, R.2
-
22
-
-
0035808173
-
A potential role for protein kinase C-epsilon in regulating megakaryocytic lineage commitment
-
Racke FK, Wang D, Zaidi Z, Kelley J, Visvader J, Soh JW et al. (2001). A potential role for protein kinase C-epsilon in regulating megakaryocytic lineage commitment. J Biol Chem 276: 522-528.
-
(2001)
J Biol Chem
, vol.276
, pp. 522-528
-
-
Racke, F.K.1
Wang, D.2
Zaidi, Z.3
Kelley, J.4
Visvader, J.5
Soh, J.W.6
-
23
-
-
33644974753
-
Transient or long-term silencingof BCR-ABL alone induces cell cycle and proliferation arrest, apoptosis and differentiation
-
Rangatia J, Bonnet D. (2005). Transient or long-term silencingof BCR-ABL alone induces cell cycle and proliferation arrest, apoptosis and differentiation. Leukemia 20: 68-76.
-
(2005)
Leukemia
, vol.20
, pp. 68-76
-
-
Rangatia, J.1
Bonnet, D.2
-
24
-
-
0141788346
-
STI-571: An anticancer protein-tyrosine kinase inhibitor
-
Roskoski Jr R. (2003). STI-571: an anticancer protein-tyrosine kinase inhibitor. Biochem Biophys Res Commun 309: 709-717.
-
(2003)
Biochem Biophys Res Commun
, vol.309
, pp. 709-717
-
-
Roskoski Jr, R.1
-
25
-
-
0037441756
-
Specific inhibition of bcr-abl gene expression by small interfering RNA
-
Scherr M, Battmer K, Winkler T, Heidenreich O, Ganser A, Eder M. (2003). Specific inhibition of bcr-abl gene expression by small interfering RNA. Blood 101: 1566-1569.
-
(2003)
Blood
, vol.101
, pp. 1566-1569
-
-
Scherr, M.1
Battmer, K.2
Winkler, T.3
Heidenreich, O.4
Ganser, A.5
Eder, M.6
-
26
-
-
1242307380
-
JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis
-
Steelman LS, Pohnert SC, Shelton JG, Franklin RA, Bertrand FE, McCubrey JA. (2004). JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis. Leukemia 18: 189-218.
-
(2004)
Leukemia
, vol.18
, pp. 189-218
-
-
Steelman, L.S.1
Pohnert, S.C.2
Shelton, J.G.3
Franklin, R.A.4
Bertrand, F.E.5
McCubrey, J.A.6
-
27
-
-
10744219596
-
Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector
-
van de Wetering M, Oving I, Muncan V, Pon Fong MT, Brantjes H, van Leenen D et al. (2003). Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep 4: 609-615.
-
(2003)
EMBO Rep
, vol.4
, pp. 609-615
-
-
van de Wetering, M.1
Oving, I.2
Muncan, V.3
Pon Fong, M.T.4
Brantjes, H.5
van Leenen, D.6
-
28
-
-
33644853211
-
RNA interference targeting of Bcr-Abl increases chronic myeloid leukemia cell killingby 17-allylamino-17- demethoxygeldanamycin
-
Withey JM, Harvey AJ, Crompton MR. (2005). RNA interference targeting of Bcr-Abl increases chronic myeloid leukemia cell killingby 17-allylamino-17- demethoxygeldanamycin. Leuk Res 30: 553-560.
-
(2005)
Leuk Res
, vol.30
, pp. 553-560
-
-
Withey, J.M.1
Harvey, A.J.2
Crompton, M.R.3
-
29
-
-
0141790842
-
Inhibition of bcr-abl gene expression by small interfering RNA sensitizes for imatinib mesylate (STI571)
-
Wohlbold L, Van der Kuip H, Miething C, Vornlocher HP, Knabbe C, Duyster J et al. (2003). Inhibition of bcr-abl gene expression by small interfering RNA sensitizes for imatinib mesylate (STI571). Blood 102: 2236-2239.
-
(2003)
Blood
, vol.102
, pp. 2236-2239
-
-
Wohlbold, L.1
Van der Kuip, H.2
Miething, C.3
Vornlocher, H.P.4
Knabbe, C.5
Duyster, J.6
-
30
-
-
18544366598
-
PD166326, a novel tyrosine kinase inhibitor, has greater antileukemic activity than imatinib mesylate in a murine model of chronic myeloid leukemia
-
Wolff NC, Veach DR, Tong WP, Bornmann WG, Clarkson B, Ilaria Jr RL. (2005). PD166326, a novel tyrosine kinase inhibitor, has greater antileukemic activity than imatinib mesylate in a murine model of chronic myeloid leukemia. Blood 105: 3995-4003.
-
(2005)
Blood
, vol.105
, pp. 3995-4003
-
-
Wolff, N.C.1
Veach, D.R.2
Tong, W.P.3
Bornmann, W.G.4
Clarkson, B.5
Ilaria Jr, R.L.6
-
31
-
-
2542441665
-
The BCR-ABL story: Bench to bedside and back
-
Wong S, Witte ON. (2004). The BCR-ABL story: bench to bedside and back. Annu Rev Immunol 22: 247-306.
-
(2004)
Annu Rev Immunol
, vol.22
, pp. 247-306
-
-
Wong, S.1
Witte, O.N.2
-
32
-
-
0035862331
-
Caspase activation is required for terminal erythroid differentiation
-
Zermati Y, Garrido C, Amsellem S, Fishelson S, Bouscary D, Valensi F et al. (2001). Caspase activation is required for terminal erythroid differentiation. J Exp Med 193: 247-254.
-
(2001)
J Exp Med
, vol.193
, pp. 247-254
-
-
Zermati, Y.1
Garrido, C.2
Amsellem, S.3
Fishelson, S.4
Bouscary, D.5
Valensi, F.6
|